Top Markets
#1 GoPlus Security GoPlus Security +31.51%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.70%
#3 Status Status +17.55%
#4 Wrapped NXM Wrapped NXM +14.47%
#5 Pons Pons +10.73%
#6 BankrCoin BankrCoin +10.62%
#7 Bedrock Bedrock +10.01%
#8 Ontology Gas Ontology Gas +9.25%
#9 DMT-NAT DMT-NAT +8.78%
#10 Janction Janction +7.19%
Coin of the day
GoPlus Security GoPlus Security
Settings
Language
ENGLISH
Currency
USD
Theme
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Rank in Stocks #33997
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Share Price
$0.1502
Last synced: 2024-11-04
Market Cap
$6.43M
Change (1 day)
-5.45%
Change (1 year)
0.00%
Country
US
Trade Renalytix Plc (RNLX)

Category

Healthcare
Earnings for Renalytix Plc (RNLX)
Earnings in Sep 2024 TTM: $-28.67M
According to Renalytix Plc latest financial reports the company's current earnings are $-28.67M. In 2023 the company made an earning of $-46.22M, a decrease compared to its 2022 earnings that were of $-45.25M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Renalytix Plc from 2018 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-28.67M -14.29%
2024 $-33.45M -27.63%
2023 $-46.22M 2.14%
2022 $-45.25M 26.44%
2021 $-35.79M 237.30%
2020 $-10.61M 62.78%
2019 $-6.52M 1,459.33%
2018 $-418.00K 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
$2.04B -7,225.67%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
$222.34M -875.49%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
$295.53M -1,130.77%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
$-259.89M 806.47%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
- -
US